This means that by week three or four of treatment, your blood levels reach a consistent range where the amount injected weekly roughly equals the amount your body eliminates weekly
The SELECT trial showed that Wegovy (semaglutide 2.4 mg) cuts the risk of heart attack, stroke, or cardiovascular death by 20% in people with obesity and heart disease - but no diabetes
It is essential to understand that this designation reflects absence of FDA-standard evidence , not documented evidence of harm
While it does require commitment to lifestyle changes and follow-up care, the cost is typically a single upfront investment rather than a repeated expense, making it a more cost-effective long-term option for many patients
At that time, rumors about celebrities on the drug began to circulate, and media coverage around appetite suppressants and their potential health benefits skyrocketed